Casper Sleep (CSPR) drops 12.62% on Strong Volume January 14

Equities Staff  |

Casper Sleep Inc (NYSE: CSPR) shares dropped 12.62%, or $0.78 per share, to close Friday at $5.40. After opening the day at $6.16, shares of Casper Sleep fluctuated between $6.17 and $5.39. 5,631,447 shares traded hands an increase from their 30 day average of 1,238,283. Friday's activity brought Casper Sleep’s market cap to $224,762,256.

About Casper Sleep Inc

About Casper Casper believes everyone should sleep better. The Sleep Company has a full portfolio of obsessively engineered sleep products-including mattresses, pillows, bedding, and furniture-designed in-house by the Company's award-winning R&D team at Casper Labs in San Francisco. In addition to its e-commerce business, Casper owns and operates 59 Sleep Shops across North America and its products are available at a growing list of retailers.

Visit Casper Sleep Inc’s profile for more information.

About The New York Stock Exchange

The New York Stock Exchange is the world’s largest stock exchange by market value at over $26 trillion. It is also the leader for initial public offerings, with $82 billion raised in 2020, including six of the seven largest technology deals. 63% of SPAC proceeds in 2020 were raised on the NYSE, including the six largest transactions.

To get more information on Casper Sleep Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Casper Sleep Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Algoma Steel Upgrades Power Plant in Transition to Green Steelmaking
Insulet Gets FDA Clearance for Omnipod 5 Automated Insulin Delivery System
Russell 2000 Enters Bear Market Territory for First Time in Nearly Two Years
TG Therapeutics Tumbles 40% on Partial Clinical Trial Hold
Huawei Says Carrier Business Stable as Revenues Decline: Jeff Kagan
Time To Reconsider Galapagos as New CEO Paul Stoffels Named
Global Politics Could Drive Extreme Market Volatility in 2022
Stock Stage Sharp Monday Afternoon Rally To Erase Morning Losses



Market Movers

Sponsored Financial Content